Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Corporate Governance
Stock Information
02186.HK
1.78 0.01  (0.56%)
TradingVolume：6469
04-11
2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Publisher：
03-31
2023
LURBINECTEDIN FOR INJECTION (LY01017) GRANTED PRIORITY REVIEW BY CHINA'S CDE FOR TREATING SMALL CELL LUNG CANCER
Publisher：
03-29
2023
Terms of Reference for the Environmental, Social and Governance Committee of the board of directors of the Company
Publisher：
03-29
2023
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Publisher：
08-30
2015
List of Directors and their Role and Function
Publisher：
08-30
2015
Procedures for Shareholders to Propose a Director
Publisher：
08-30
2015
Terms of Reference for Remuneration Committee
Publisher：
08-30
2015
Terms of Reference for Nomination Committee
Publisher：
08-30
2015
Terms of Reference for Audit Committee
Publisher：
08-29
2015
Altered Memorandum of Association and Bye-laws
Publisher：
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：6469
1.78
0.01  (0.56%)
Corporate Governance
04-11
2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
03-31
2023
LURBINECTEDIN FOR INJECTION (LY01017) GRANTED PRIORITY REVIEW BY CHINA'S CDE FOR TREATING SMALL CELL LUNG CANCER
03-29
2023
Terms of Reference for the Environmental, Social and Governance Committee of the board of directors of the Company
03-29
2023
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
08-30
2015
List of Directors and their Role and Function
08-30
2015
Procedures for Shareholders to Propose a Director
08-30
2015
Terms of Reference for Remuneration Committee
08-30
2015
Terms of Reference for Nomination Committee
08-30
2015
Terms of Reference for Audit Committee
08-29
2015
Altered Memorandum of Association and Bye-laws